InsidersTradesSigma
Oryzon Genomics, S.A.: directors' dealings · Spain · CNMV
CNMV:oryzon-genomics-saES0167733015ES·CNMVMcap 232M€Healthcare
Explore the full insider trade history of Oryzon Genomics, S.A., a publicly traded company based in Spain. Shares trade on ES ES, under the supervision of CNMV. Operating in the Healthcare sector, Oryzon Genomics, S.A. has recorded 3 public disclosures. Market capitalisation: €232.3m. The latest transaction was reported on 13 February 2023 (Other). Among the most active insiders: DOUGLAS FALLER. Every trade is accessible without an account.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.95 €
Analyst consensus
4 analystsStrong buy
4.00 €Target 7.45 €(+153%)12.00 €
Income statement
Gross profit10.7 M€
Net income−2.6 M€-20.4% margin
Valuation
PER (forward)137.0x
P/Book1.9x
Balance sheet & cash
Market cap232.3 M€
Total debt7.6 M€
Free Cash Flow−13.4 M€
Profitability & ownership
% insiders21.3%
% institutions0.8%
Last declaration on 13 February 2023
Declarations3 total
Executives●Other25CNMV
€25,60010,000 shares@ €2.560.011% mcap100.0% of flow
ShareXOOF
CNMV:2023022698·
Executives●Other36CNMV
€24,80010,000 shares@ €2.480.011% mcap100.0% of flow
ShareXOOF
CNMV:2023021941·
Executives●Other26CNMV
€30,36012,000 shares@ €2.530.013% mcap100.0% of flow
ShareXOOF
CNMV:2023020065·
3 of 3 declarations